Characterization and immunological determination of the complex between prostate-specific antigen and...

Area of Science:

• Biochemistry
• Clinical Chemistry
• Oncology

Background:

• Prostate-specific antigen (PSA) forms complexes with alpha2-macroglobulin (A2M), rendering it undetectable by standard immunoassays.
• Encapsulation within A2M prevents the detection of PSA-A2M complexes by conventional PSA tests.

Purpose of the Study:

• To develop a novel dissociation assay for detecting PSA-A2M complexes.
• To evaluate the diagnostic utility of PSA-A2M measurements in distinguishing prostate cancer (PCa) from benign prostatic hyperplasia (BPH).

Main Methods:

• Developed a dissociation assay involving high pH denaturation to release immunoreactive PSA from PSA-A2M complexes.
• Utilized immunoadsorption to remove free PSA, followed by denaturation and measurement of released PSA.
• Calibrated the assay using in vitro generated PSA-A2M and validated with patient serum samples.

Main Results:

• The dissociation assay demonstrated a low detection limit (0.14 microg/L) and good reproducibility.
• A strong correlation was observed between PSA-A2M formation and loss of PSA immunoreactivity.
• Serum PSA-A2M levels correlated with total PSA in both BPH and PCa, but the PSA-A2M to total PSA ratio was significantly higher in BPH.

Conclusions:

• The developed dissociation assay effectively measures PSA-A2M complexes.
• Measuring the ratio of PSA-A2M to total PSA enhances diagnostic accuracy for prostate cancer compared to total PSA alone.
• This approach offers a promising tool for improving PCa detection and differentiation from BPH.